• OPEN AN ACCOUNT
Indian Indices
Sensex
82,269.78 -296.59
( -0.36%)
Global Indices
Nasdaq
48,928.31 -164.26
(-0.33%)
Dow Jones
6,963.16 -26.85
(-0.38%)
Hang Seng
53,392.10 16.50
(0.03%)
Nikkei 225
10,214.90 43.14
(0.42%)
Forex
USD-INR
91.92 0.08
(0.09%)
EUR-INR
109.97 0.03
(0.03%)
GBP-INR
126.94 0.27
(0.21%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Johnson Pharmacare Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532154
INE560F01022
1.0202255
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
28.05
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

bn holdings ltd
Pavna Inds gains after signing MoU with Tamil Nadu Govt to build auto-component facility
Sep 17,2025
As part of the MoU, the Government of Tamil Nadu has assured its full support and facilitation for the timely and effective execution of the project. The proposed facility will further enhance the company’s manufacturing footprint, strengthen its position in the automotive ecosystem, and contribute to the state’s vision of advancing as a hub for future mobility solutions.

Swapnil Jain, managing director, Pavna Industries, said, “We are proud to partner with the Government of Tamil Nadu for this project, which will generate employment, create new opportunities for local talent, and support the state’s thriving automotive ecosystem.

This initiative is closely aligned with the Make in India vision and underscores Pavna Industries’ dedication to nation-building through world-class manufacturing. We value the support extended by the Government of Tamil Nadu in enabling this expansion.”

Pavna Industries engaged in the business of manufacturing wide range of high-quality automotive parts for reputed OEMs serving different vehicle segments including passenger vehicles, two-wheelers, three-wheelers, heavy and light commercial vehicles, and off-road vehicles.

The company reported consolidated net loss of Rs 2.10 crore in Q1 FY26 compared with net profit of Rs 2.23 crore in Q1 FY25. Net sales declined 23.4% YoY to Rs 60.40 crore in Q1 FY26.